In the last trading session, 3.04 million shares of the Adma Biologics Inc (NASDAQ:ADMA) were traded, and its beta was 0.56. Most recently the company’s share price was $23.12, and it changed around -$0.59 or -2.49% from the last close, which brings the market valuation of the company to $5.52B. ADMA currently trades at a discount to its 52-week high of $25.67, offering almost -11.03% off that amount. The share price’s 52-week low was $6.72, which indicates that the current value has risen by an impressive 70.93% since then.
Adma Biologics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.50. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended ADMA as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight.
Adma Biologics Inc (NASDAQ:ADMA) trade information
Instantly ADMA has showed a red trend with a performance of -2.49% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 24.19 on recent trading dayincreased the stock’s daily price by 4.42%. The company’s shares are currently up 34.81% year-to-date, but still down -4.11% over the last five days. On the other hand, Adma Biologics Inc (NASDAQ:ADMA) is 28.37% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $16, which translates to bulls needing to decrease their stock price by -44.5% from its current value. Analyst projections state that ADMA is forecast to be at a low of $14 and a high of $18.
Adma Biologics Inc earnings are expected to increase by 45.61% in 2025, but the outlook is positive 29.88% per year for the next five years.
ADMA Dividends
Adma Biologics Inc’s next quarterly earnings report is expected to be released in June.
VANGUARD GROUP INC, with 6.2459% or 14.52 million shares worth $162.3 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
iShares Trust-iShares Core S&P Small-Cap ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 14.62 shares worth $337.96 million, making up 6.13% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held roughly 7.0 shares worth around $161.88 million, which represents about 2.93% of the total shares outstanding.
